The L-amino acid carrier inhibitor 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) reduces L-dopa-elicited responses in dopaminergic neurons of the substantia nigra pars compacta.

@article{Sebastianelli2008TheLA,
  title={The L-amino acid carrier inhibitor 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) reduces L-dopa-elicited responses in dopaminergic neurons of the substantia nigra pars compacta.},
  author={Luca Sebastianelli and Ada Ledonne and Maria Cristina Marrone and Giorgio Bernardi and Nicola Biagio Mercuri},
  journal={Experimental neurology},
  year={2008},
  volume={212 1},
  pages={230-3}
}
It is not yet clear how L-dopa, that is the most effective drug for the treatment of Parkinson's disease, enters into the dopaminergic neurons to be transformed into dopamine. It is suggested that L-dopa is mainly transported into cells by a group of L-amino acid carriers named "System L". Since these carriers are selectively inhibited by 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH), we have applied this compound to electrophysiologically recorded dopaminergic neurons of the rat… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration

  • A. L. McCormack, D. A. Di Monte
  • J. Neurochem
  • 2003

Similar Papers

Loading similar papers…